{"id":88092,"date":"2026-05-15T17:11:02","date_gmt":"2026-05-15T11:41:02","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=88092"},"modified":"2026-05-15T17:11:03","modified_gmt":"2026-05-15T11:41:03","slug":"caplin-point-laboratories-q4-fy26-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/caplin-point-laboratories-q4-fy26-results\/","title":{"rendered":"Caplin Point Laboratories Q4 FY26 Results: PAT of Rs 170.11 crore (up 17.9% YoY) Pharmaceuticals &#8211; Latin America Generic Formulations"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p><a href=\"https:\/\/univest.in\/user\/stocks\/caplipoint\/caplin-point-laboratories-ltd-share-price-today\">Caplin Point Laboratories<\/a> results were announced on May 14, 2026, at the company&#8217;s board meeting. the company PAT was Rs 170.11 crore (+17.9% YoY from Rs 144.32 crore). Revenue Rs 628.52 crore (+19% YoY from Rs 528.19 crore). FY26 annual PAT Rs 641.24 crore (+19.6% from Rs 536.31 crore). FY26 revenue Rs 2,302.73 crore (+13.2%). FY26 EPS Rs 84.11 vs Rs 70.25. Strong execution in regulated Latin American markets continues. Investors tracking the company will find complete financial data, analysis, and FY27 outlook in this article.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here \u2013 Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/caplin-point-laboratories-q4-fy26-results\/#Caplin_Point_Laboratories_Q4_FY26_Key_Financial_Highlights\" title=\"Caplin Point Laboratories Q4 FY26 Key Financial Highlights\">Caplin Point Laboratories Q4 FY26 Key Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/caplin-point-laboratories-q4-fy26-results\/#Caplin_Point_Laboratories_Performance_Analysis\" title=\"Caplin Point Laboratories Performance Analysis\">Caplin Point Laboratories Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/caplin-point-laboratories-q4-fy26-results\/#Caplin_Point_Laboratories_FY27_Outlook\" title=\"Caplin Point Laboratories FY27 Outlook\">Caplin Point Laboratories FY27 Outlook<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/caplin-point-laboratories-q4-fy26-results\/#Frequently_Asked_Questions_on_Caplin_Point_Laboratories_Q4_FY26_Results\" title=\"Frequently Asked Questions on Caplin Point Laboratories Q4 FY26 Results\">Frequently Asked Questions on Caplin Point Laboratories Q4 FY26 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/caplin-point-laboratories-q4-fy26-results\/#What_is_Caplin_Point_Laboratories_Q4_FY26_PAT\" title=\"What is Caplin Point Laboratories Q4 FY26 PAT?\">What is Caplin Point Laboratories Q4 FY26 PAT?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/caplin-point-laboratories-q4-fy26-results\/#When_did_Caplin_Point_Laboratories_announce_Q4_FY26_results\" title=\"When did Caplin Point Laboratories announce Q4 FY26 results?\">When did Caplin Point Laboratories announce Q4 FY26 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/caplin-point-laboratories-q4-fy26-results\/#What_is_the_FY27_outlook_for_Caplin_Point_Laboratories\" title=\"What is the FY27 outlook for Caplin Point Laboratories?\">What is the FY27 outlook for Caplin Point Laboratories?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/caplin-point-laboratories-q4-fy26-results\/#Where_can_I_track_Caplin_Point_Laboratories_Q4_FY26_live_data\" title=\"Where can I track Caplin Point Laboratories Q4 FY26 live data?\">Where can I track Caplin Point Laboratories Q4 FY26 live data?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Caplin_Point_Laboratories_Q4_FY26_Key_Financial_Highlights\"><\/span><strong>Caplin Point Laboratories Q4 FY26 Key Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th><strong>Metric<\/strong><\/th>\n<th><strong>Q4 FY26<\/strong><\/th>\n<th><strong>Comparison<\/strong><\/th>\n<\/tr>\n<tr>\n<td><strong>PAT (Net Profit)<\/strong><\/td>\n<td>Rs 170.11 crore<\/td>\n<td>Q4 FY25 \/ Reference | up 17.9% YoY from Rs 144.32 crore<\/td>\n<\/tr>\n<tr>\n<td><strong>Revenue from Operations<\/strong><\/td>\n<td>Rs 628.52 crore<\/td>\n<td>Q4 FY26 Revenue | up 19% YoY from Rs 528.19 crore<\/td>\n<\/tr>\n<tr>\n<td><strong>Ticker<\/strong><\/td>\n<td>CAPLIPOINT<\/td>\n<td>Sector: Pharmaceuticals &#8211; Latin America Generic Formulations<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Screen the best stocks on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Caplin_Point_Laboratories_Performance_Analysis\"><\/span><strong>Caplin Point Laboratories Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The company results reflect the company&#8217;s operational performance during the January to March 2026 quarter. the company PAT was Rs 170.11 crore (+17.9% YoY from Rs 144.32 crore). Revenue Rs 628.52 crore (+19% YoY from Rs 528.19 crore). FY26 annual PAT Rs 641.24 crore (+19. Investors and analysts monitoring the company results will focus on FY27 revenue guidance, margin trajectory, and management commentary on business outlook.<\/p>\n<p>The company performance positions the company for FY27. Track the company analyst ratings and live stock price on the Univest Screener for real-time investment insights.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Caplin_Point_Laboratories_FY27_Outlook\"><\/span><strong>Caplin Point Laboratories FY27 Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Post <strong>Caplin<\/strong>, investor focus for FY27 will be on revenue growth momentum, margin expansion, new order wins, and sector-specific tailwinds in the Pharmaceuticals &#8211; Latin America Generic Formulations space. The <strong>Caplin<\/strong> results demonstrate the company&#8217;s execution capabilities. Track <strong>Caplin<\/strong> updates on the Univest Screener for analyst views and FY27 earnings estimates.<\/p>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track live price and Q4 FY26 earnings updates.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Caplin_Point_Laboratories_Q4_FY26_Results\"><\/span><strong>Frequently Asked Questions on Caplin Point Laboratories Q4 FY26 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Caplin_Point_Laboratories_Q4_FY26_PAT\"><\/span><strong>What is Caplin Point Laboratories Q4 FY26 PAT?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> <strong>Caplin Point Laboratories Q4 FY26<\/strong> profit after tax was Rs 170.11 crore, up 17.9% YoY from Rs 144.32 crore in Q4 FY25..<\/p>\n<h3><span class=\"ez-toc-section\" id=\"When_did_Caplin_Point_Laboratories_announce_Q4_FY26_results\"><\/span><strong>When did Caplin Point Laboratories announce Q4 FY26 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> the company results were announced on May 14, 2026, at the company&#8217;s board meeting and filed with BSE and NSE.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_FY27_outlook_for_Caplin_Point_Laboratories\"><\/span><strong>What is the FY27 outlook for Caplin Point Laboratories?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Post the company results, investors will track FY27 guidance and growth strategies in the Pharmaceuticals &#8211; Latin America Generic Formulations sector. Track live updates on the Univest Screener.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_Caplin_Point_Laboratories_Q4_FY26_live_data\"><\/span><strong>Where can I track Caplin Point Laboratories Q4 FY26 live data?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Track the company live stock price, analyst ratings, and earnings updates on the Univest Screener for real-time investment data.<\/p>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Consult a SEBI-registered advisor before making any investment decision.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Caplin Point Laboratories Q4 FY26 results: Caplin Point Laboratories Q4 FY26 consolidated PAT was Rs 170.11 crore (+17.9% YoY from Rs 144.32 crore). Revenue Rs 628.52 cro<\/p>\n","protected":false},"author":26,"featured_media":88674,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-88092","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1778845277:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["76"],"rank_math_focus_keyword":["Caplin Point Laboratories Q4"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Caplin Point Laboratories Q4 FY26: PAT Rs 170.11 Crore"],"rank_math_description":["Caplin Point Laboratories Q4 FY26 results: Caplin Point Laboratories Q4 FY26 PAT was Rs 170.11 crore (+17.9% YoY from Rs 144.32 crore). Revenue Rs 628.52 cro"],"_thumbnail_id":["88674"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["11711"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/05\/15171041\/Caplin-Point-Laboratories-Q4-FY26-Results.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/88092","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=88092"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/88092\/revisions"}],"predecessor-version":[{"id":88676,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/88092\/revisions\/88676"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/88674"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=88092"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=88092"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=88092"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}